The group’s principle activity is to improve human healthcare through bridging gaps in the biotechnology world by global introduction of innovative technologies, research and drug development tools, technology transfer services, and by providing incubation resources for startup companies. The group’s products include Apoptosis, Elisa Assay, and PCR enzymes. The group operates from United States.
Executive Information
Name
Title
Email
Hiro Masumoto
Founder, CEO, Pres.
N/A
Paul Diehl
Dir. - Commercial Operations
N/A
Takayuki Mizutani
Dir. - Business Development
N/A
Masahiko Kuroda
Assoc. Professor - Department, Pathology, Tokyo Medical University
